NDC 17856-0672-01 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0672
- Requested NDC
- 17856-0672-01
- Package NDCs from labels
- 17856-0672-1, 17856-0672-2, 17856-0672-3, 17856-0672-4, 17856-0672-01
- Manufacturer
- Atlantic Biologics Corp.
- Effective date
- 2025-10-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - Atlantic Biologics Corp. | Atlantic Biologics Corp. | 2025-10-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0672-1 | Ondansetron | 60 in 1 CASE | SOLUTION | 60 | 1 | |
| 17856-0672-1 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-2 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-2 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-3 | Ondansetron | 120 in 1 CASE | SOLUTION | 120 | 1 | |
| 17856-0672-3 | Ondansetron | 2.5 mL in 1 SYRINGE | SOLUTION | 2.5 | 1 | |
| 17856-0672-4 | Ondansetron | 72 in 1 CASE | SOLUTION | 72 | 1 | |
| 17856-0672-4 | Ondansetron | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0672-1 | ML - Milliliter | 17856-0672 | f5b97fd9-6050-46e6-b0da-693821d3938a | 1 | 2026-03-17 |
| 17856-0672-2 | ML - Milliliter | 17856-0672 | 787cc894-2cc2-4952-981c-f67609a087e3 | 1 | 2026-03-17 |
| 17856-0672-3 | ML - Milliliter | 17856-0672 | 53831650-5a50-4e31-9590-1c0ac60dc7ec | 1 | 2026-03-17 |
| 17856-0672-4 | ML - Milliliter | 17856-0672 | 68c3eadb-fcbb-40cc-80d0-0ddc4021b83a | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hemorrhoidal Cream | HEMORRHOIDAL CREAM | Walgreens | 4276ddad-2363-462a-bb97-574f946ec3f0 | 2026-01-15 | Warnings | PDC6A3C0OX |
| Hemorrhoid and Fissure | GLYCERIN 6%,LIDOCAINE 4%,ECTOIN 0.12% | FlexiGo Inc | 48697377-61c0-1b0a-e063-6294a90a3293 | 2026-01-15 | Warnings | PDC6A3C0OX |
| CVS Pharmacy Glycerin Laxative | GLYCERIN | CVS Pharmacy | a73404d5-7843-4a9a-ad43-613df22f52e7 | 2026-01-14 | Warnings | PDC6A3C0OX |
| CVS Pharmacy Glycerin Laxative | GLYCERIN | CVS Pharmacy | eff2f43e-5626-48eb-a70e-334492977204 | 2026-01-14 | Warnings | PDC6A3C0OX |
| CVS Pharmacy Glycerin Laxative | GLYCERIN | CVS Pharmacy | c92ca67b-bea2-4be0-95ab-15f9b55568c1 | 2026-01-14 | Warnings | PDC6A3C0OX |
| Rite-Aid Glycerin Laxative | GLYCERIN SUPPOSITORY | RITE AID CORPORATION | 0fb8f488-3386-29b9-e063-6294a90a014c | 2026-01-14 | Warnings | PDC6A3C0OX |
| Rite-Aid Childrens Glycerin Laxative | GLYCERIN SUPPOSITORY | RITE AID CORPORATION | 0fbe4dfd-1d5d-fc31-e063-6394a90ab317 | 2026-01-14 | Warnings | PDC6A3C0OX |
| GNP Hemorrhoidal Maximum Strength | HEMORRHOIDAL | Amerisourcebergen Drug Corporation | 24103355-cd72-55b0-e063-6394a90a90ec | 2026-01-14 | Warnings | PDC6A3C0OX |
| Hemorrhoid, Fissure, ProctalgiaSuppositories | CARBON, MIRABILITE, PEPPERMINT OIL, BORNEOL | WU XI ZHONG ZHI WEI NA TECHNOLOGY CO., Ltd. | 1d40d16a-ee52-463a-e063-6394a90a6077 | 2026-01-14 | Warnings | PDC6A3C0OX |
| Anal Care GLO pack | CARBON, MIRABILITE, PEPPERMINT OIL, BORNEOL | WU XI ZHONG ZHI WEI NA TECHNOLOGY CO., Ltd. | 26612dae-21a0-6f12-e063-6394a90afe93 | 2026-01-14 | Warnings | PDC6A3C0OX |
| Hemorrhoid, Fissure, Proctalgia Relief Wash | CARBON, PANTHENOL, SODIUM HYALURONATE | WU XI ZHONG ZHI WEI NA TECHNOLOGY CO., Ltd. | 1e20de39-45b0-54ec-e063-6294a90a04ed | 2026-01-14 | Warnings | PDC6A3C0OX |
| Hemorrhoid, Fissure, Proctalgia Ointments | CARBON, MIRABILITE, PEPPERMINT OIL, BORNEOL, GLYCERIN | WU XI ZHONG ZHI WEI NA TECHNOLOGY CO., Ltd. | 1efe43d5-a29b-5cb2-e063-6394a90aca66 | 2026-01-14 | Warnings | PDC6A3C0OX |
| ONDANSETRON HYDROCHLORIDE | ONDANSETRON HYDROCHLORIDE | Cardinal Health 107, LLC | 30107d6f-5128-484f-b713-65244a98dc67 | 2026-01-14 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | AvPAK | 05cf8d4f-ac57-4177-e063-6394a90ae804 | 2026-01-09 | Warnings, Adverse reactions | 312085 NMH84OZK2B |
| ST MORIZ SUNCARE BODY SUNSCREEN SPF30 | SUNCARE BODY SUNSCREEN SPF30 | Aopline Biotechnology (Guangzhou) Co., Ltd. | 48026f09-6d15-8fa6-e063-6294a90a17cb | 2026-01-09 | Warnings | PDC6A3C0OX |
| Ondansetron | ONDANSETRON | Glenmark Pharmaceuticals Inc., USA | eee5217a-eba8-463a-812d-bf3c66f0934f | 2026-01-08 | Warnings, Adverse reactions | NMH84OZK2B |
| Brain Enhancement Liquescence 3006 | BRAIN ENHANCEMENT LIQUESCENCE | Professional Complementary Health Formulas | 33bb2104-c16a-49e4-b292-69e10c1f16c0 | 2026-01-08 | Warnings | PDC6A3C0OX |
| Preparation H Rapid Relief | GLYCERIN, LIDOCAINE, PHENYLEPHRINE HYDROCHLORIDE | Haleon US Holdings LLC | 49a93cfc-4ccd-4ef3-928f-901b9926f794 | 2026-01-08 | Warnings | PDC6A3C0OX |
| Lemon | GLYCERIN | Sion Biotext Medical Ltd | dbd7ed86-1b92-4471-827a-89f3afa1b0dc | 2026-01-08 | Warnings | PDC6A3C0OX |
| Cell Energy Performance Drops 2048 | CELL ENERGY PERFORMANCE DROPS | Professional Complementary Health Formulas | 8701ea61-5d5f-466b-8d2c-f808e7b4d8fe | 2026-01-08 | Warnings | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.